The South Australia Cancer Genome Facility at SA Pathology is set to specialise in tailored cancer treatments thanks to ACRF seed-funding.
A grant of $3.5 million from ACRF, combined with $1.05 from the State Government and $500,000 from the Cancer Council SA, will buy state-of-the-art technology, such as gene sequencers, for the investigation of small, defined areas of DNA.
“ACRF is thrilled that our seed-funding provided the catalyst for other organisations to jump on board and fund the remaining $1.55 million required to establish this world-class facility,” Chief Executive of ACRF, Mr David Brettell said.
“ACRF’s Medical Research Advisory Committee which is chaired by Professor Ian Frazer (who developed the cervical cancer vaccine) was deeply impressed with the standard of the cancer research proposal from the Centre for Cancer Biology.
“But the support of the State Government and Cancer Council SA was vital in the development of the cancer genome centre, and we’re proud to have motivated their involvement.”
Professor Angel Lopez, co-director of the Centre for Cancer Biology (pictured), told the SA Advertiser about how this funding will significantly improve oncology treatments of the future:
“Sometimes we don’t need to look at the whole genome of the person but at specific genes, so go straight to the jugular, so to speak.”
Read the full Advertiser article here.
Related Posts
